Expert Pitch
Rutgers University-New Brunswick

Rutgers-Harvard-Northeastern-Northwestern Researchers Release New 50-State Survey Data on COVID-19

8-Jul-2020 11:15 AM EDT, by Rutgers University-New Brunswick

Rutgers scholar Katherine Ognyanova is available to comment on the latest Rutgers-Harvard-Northeastern-Northwestern survey data from The COVID-19 Consortium for Understanding the Public’s Policy Preferences Across States.

The researchers surveyed 22,501 people across all 50 states plus the District of Columbia from June 12 to June 28. The researchers polled participants about how the President and governors responded to COVID-19.

To view the full report and findings, click here.

Among the findings:

  • The average governor has experienced a 9.8 point decline in approval. Only five states—New Jersey, Hawaii, Michigan, South Dakota and Vermont— saw their governors’ approval ratings increase; approval rates declined in the other 45.
  • In many Northeast, Midwest and West Coast states that were hardest hit early in the pandemic, even those governors whose approval ratings declined still maintained higher ratings than other governors throughout the crisis.
  • President Trump started with a relatively low approval rating (below those of all 50 governors), and has declined further, by 8.2 points. Only Governor Ducey of Arizona has a lower rating. The president’s approval rating is fairly low everywhere, hovering around 50% in Montana, Wyoming and North Dakota, and lower everywhere else.
  • Exploration of the erosion of support for the president suggests that this decline is fairly similar across parties, race and ethnicity, age, income, and education.
  • Trump’s popularity has declined from 56% to 42% among older respondents with a high school education or less.
  • Governor Ducey of Arizona has the lowest approval for his COVID-19 response of any governor in the country, dropping from a high of 57% in early May to 32% in late June.

Katherine Ognyanova is an assistant professor at Rutgers’ School of Communication and Information. She conducts research in network science, computational social science, social technology, media, civic and political communication.

Additional collaborators on the report include: David Lazer, Alexi Quintana, Matthew Simonson and Hanyu Chwe of Northeastern University; Matthew A. Baum and John Della Volpe of Harvard University; James Druckman of Northwestern University; Roy H. Perlis and Mauricio Santillana of Harvard Medical School

###

Broadcast interviews: Rutgers University–New Brunswick has broadcast-quality TV and radio studios available for remote live or taped interviews with Rutgers experts. For more information, contact Neal Buccino neal.buccino@echo.rutgers.edu

ABOUT RUTGERS—NEW BRUNSWICK

Rutgers University–New Brunswick is where Rutgers, the State University of New Jersey, began more than 250 years ago. Ranked among the world’s top 60 universities, Rutgers’s flagship university is a leading public research institution and a member of the prestigious Association of American Universities. It is home to internationally acclaimed faculty and has 12 degree-granting schools and a Division I Athletics program. It is the Big Ten Conference’s most diverse university. Through its community of teachers, scholars, artists, scientists, and healers, Rutgers is equipped as never before to transform lives.

 




Filters close

Showing results

110 of 2816
access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 4:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded uab-department-of-pathology-develops-strategy-to-support-guidesafe-entry-testing-process-more-than-200-000-samples
VIDEO
Released: 5-Aug-2020 4:10 PM EDT
UAB Department of Pathology develops strategy to support GuideSafe™ Entry Testing, process more than 200,000 samples
University of Alabama at Birmingham

This strategy will allow for ramping up testing capacity tenfold for the next 20-plus days leading up to the start of school.

Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.


Showing results

110 of 2816

close
2.14178